{"schema_version":"1","generated_at":"2026-11-04T09:41:49.456Z","data_as_of":null,"url":"https://www.findmykol.com/kol/jean-siedel","json_url":"https://www.findmykol.com/kol/jean-siedel/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"jean-siedel","name":"Jean Siedel","credential":"DO","specialty":"Gynecologic Oncology","specialty_raw":"Gynecologic Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Michigan","institution_url":"https://www.findmykol.com/institution/university-of-michigan","city":"Ann Arbor","state":"MI","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1134448657","orcid":"0000-0002-2596-3634","openalex":"A5081634480"},"summary":"Jean Siedel is an Oncology physician affiliated with University of Michigan. OpenAlex indexes 45 publications with 1,290 citations (h-index 9).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":45,"cited_by_count":1290,"h_index":9,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":4,"shown":3,"withheld":1,"rows":[{"payer":"Daiichi Sankyo","program_year":2025,"amount_usd":56000,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1134448657"},{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":130.14,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1134448657"},{"payer":"Merck & Co.","program_year":2023,"amount_usd":17384.03,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1134448657"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1134448657","source":"payments"},"prescribing":{"data_year":2023,"areas_total":2,"areas_shown":2,"areas":[{"area":"Cancer & immunology","share_pct":70.3,"classes_total":2,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":37.8,"drugs":[{"name":"Letrozole","share_pct":100}],"max_beneficiaries":null},{"class":"Poly(ADP-Ribose) Polymerase Inhibitor","setting":"prescribed","share_pct":32.4,"drugs":[{"name":"Lynparza","share_pct":100}],"max_beneficiaries":null}]},{"area":"Blood & clotting","share_pct":29.7,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":29.7,"drugs":[{"name":"Eliquis","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":45,"shown":5,"withheld":40,"matched_by":"OpenAlex author record","recent":[{"title":"DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix","year":2026,"journal":"Journal for ImmunoTherapy of Cancer","source_url":"https://doi.org/10.1136/jitc-2025-012805","status":"verified"},{"title":"Vaginal Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology","year":2026,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2026.0011","status":"verified"},{"title":"Predictors of progestin response in conservatively managed endometrioid intraepithelial neoplasia and endometrial cancer","year":2026,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2026.01.702","status":"verified"},{"title":"Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study","year":2026,"journal":"JCO Precision Oncology","source_url":"https://doi.org/10.1200/po-26-00456","status":"verified"},{"title":"A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor","year":2026,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2026.07.017","status":"verified"}],"source":"works"},"contact":{"address_1":"1500 E MEDICAL CENTER DR","city":"Ann Arbor","state":"MI","zip":"481095000","phone":"734-936-4000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1134448657","source":"identity"},"similar":[{"name":"Max Wicha","slug":"max-wicha","institution":"University of Michigan","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/max-wicha","json_url":"https://www.findmykol.com/kol/max-wicha/profile.json"},{"name":"Eva Feldman","slug":"eva-feldman","institution":"University of Michigan","specialty":"Neurology","url":"https://www.findmykol.com/kol/eva-feldman","json_url":"https://www.findmykol.com/kol/eva-feldman/profile.json"},{"name":"Dinesh Khanna","slug":"dinesh-khanna","institution":"University of Michigan","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/dinesh-khanna","json_url":"https://www.findmykol.com/kol/dinesh-khanna/profile.json"},{"name":"Joshua Ehrlich","slug":"joshua-ehrlich","institution":"University of Michigan","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/joshua-ehrlich","json_url":"https://www.findmykol.com/kol/joshua-ehrlich/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":1,"publications":40}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2020-01-21","provider_certified":"2020-01-21","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}